NeogenVet Vitamin K ​1 ​ Injection

Manufacturer
Neogen Corporation - Nandino | Sparhawk
Effective date
2012-11-27
Label type
PRESCRIPTION ANIMAL DRUG LABEL
Version
1
Source
full-release
Hydrated at
2026-06-01 02:39:53

Label at a glance#

ProductVitamin K1 Injectable
Active ingredientPHYTONADIONE
Label structure9 sections

Dosage and administration

​Cattle, Calves, Horses, Swine, Sheep, and Goats: ​Acute hypotrothrombinemia (with hemorrhage): intravenously, 0.5-2.5 mg/kg body weight, at a rate not to exceed 10 mg/minute in mature animals and 5 mg/minute in newborn and very young animals. Non-acute hypoprothrombinemia: intramuscularly or subcutaneously, 0.5-2.5 mg/kg per body weight. ​Dogs and Cats: ​ Acute hypoprothrombinemia (with hemorrhage) and non-acute ...

Storage and handling

Protect from light - store in a dark place. Store at controlled room temperature between 15°-30°C (59°-86°F).

Label contents#

Full prescribing information#

USE IN SPECIFIC POPULATIONS SECTION

​FOR ANIMAL USE ONLY

​Each mL contains:

COMPONENTS

​Phytonadione..................................10 mg

Emulphor EL-719.............................70 mg

Dextrose H​2​O...............................41.2 mg

Benzyl Alcohol (preservative)............1.5%

Water for Injection..............................q.s.

STORAGE AND HANDLING SECTION

Protect from light - store in a dark place. Store at controlled room temperature between 15°-30°C (59°-86°F).

SPL UNCLASSIFIED SECTION

Rev. 7-09

V-0681-04

Item No. 09089

​Principal Display Panel Vitamin K​1​ Injection 100 mL

PACKAGE LABEL.PRINCIPAL DISPLAY PANEL

NDC: 59051-9089-5

Vitamin K​1 ​Injections

(Phytonadione) 10 mg/mL

Aqueous Colloidal

​STERILE SOLUTION

​CAUTION: ​Federal law restricts this drug to use by or on the order of a licensed veterinarian.

​NEOGEN.Vet

Net Contents: 100 mL

MULTIPLE DOSE VIAL

Vitamin K1 InjectionVitamin K1 Injection

WARNINGS SECTION

​KEEP OUT OF REACH OF CHILDREN

​Dosage and Administration:

DOSAGE & ADMINISTRATION SECTION

​Cattle, Calves, Horses, Swine, Sheep, and Goats: ​Acute hypotrothrombinemia (with hemorrhage): intravenously, 0.5-2.5 mg/kg body weight, at a rate not to exceed 10 mg/minute in mature animals and 5 mg/minute in newborn and very young animals. Non-acute hypoprothrombinemia: intramuscularly or subcutaneously, 0.5-2.5 mg/kg per body weight.

​Dogs and Cats:​ Acute hypoprothrombinemia (with hemorrhage) and non-acute hypoprothrombinemia-- 0.25-5 mg/kg subcutaneously OR intramuscularly. Use higher end dose for second generation rodenticides.

​ADVERSE REACTIONS: ​See insert for additional information.

SPL UNCLASSIFIED SECTION

Manufactured by Sparhawk laboratories, Lenexa, KS 66215

for Neogen®Corporation, Lexington, KY 40511 859-254-1221

​Package Insert

SPL PATIENT PACKAGE INSERT SECTION

​VITAMIN K​1​

​(Phytonadione)

​Injection

Vitamin K Injection

(Phytonadione)

Aqueous Colloidal Solution of Vitamin K​1​

___________________________________________________________________________________________________________

​WARNING---INTRAVENOUS USE:

​Severe reactions, including fatalities, have occurred during and immediately after INTRAVENOUS injection of Phytonadione, even when precautions have been taken to dilute the Vitamin K​1 ​and to avoid rapid infusion. Typically, these severe reactions have resembled hypersensitivity or anaphylaxis, including shock and cardiac and or respiratory arrest. Some animals have exhibited these severe reactions on receiving Vitamin K​1​ Injection for the first time.

Therefore, the intravenous route should be restricted to those situations where other routes are not feasible and the serious risk involved is considered justified.

See ADVERSE REACTION section for possible Intramuscular and Subcutaneous reactions.

_____________________________________________________________________________________________________________

​DESCRIPTION: ​Vitamin K​1 ​Injection is a yellow, sterile acqueous colloidal solution of Vitamin K​1 ​(phytonadione), available for injection by the intravenous, intramuscular and subcutaneous routes. Each mL contains:

Phytonadione...................................10 mg

Inactive Ingredients

Emulphor EL-719..............................70 mg

Dextrose H​2​O...............................41.2 mg

Water...................................................q.s.

Added as a preservative

Benzyl Alcohol....................................1.5%

​ACTIONS: ​Vitamin K​1​ Injection, an aqueous colloidal solution of Vitamin K​1 for parenteral injection, possesses the same type and degree of activity as does naturally occurring Vitamin K. The primary function of vitamin K is to stimulate the production via the liver of active prothrombin from a precursor protein. The mechanism by which vitamin K promotes formation of prothrombin at the molecular level has not been established. The action of the aqueous colloidal solution, when administered intravenously, is generally detectable within an hour or two and hemorrhage is usually controlled within 3 to 6 hours. A normal prothrombin level may often be obtained in 12 to 14 hours.

​INDICATIONS: ​Vitamin K​1​ Injection is indicated in cattle, calves, horses, swine, sheep, goats, dogs and cats to counter Hypoprothrombinemia induced by ingestion of coumarin-based compounds, common ingredients in commercial rodenticides. Vitamin K​1​ Injection is also indicated to counter hypoprothrombinemia caused by consumption of Bishydroxycoumarin found in spoiled and moldy sweet clover.

​NOTE: ​ Regualr determinations of prothrombin time response should be performed to guide in the initial and subsequent administration of Vitamin K​1​ Injection. The dosage should be adjusted accordingly.

​CONTRAINDICATIONS: ​ Hypersensitivity to any component of this medication.

​WARNINGS: ​An immediate coagulant effect should not be expected after administration of phytonadione. A minimum of 1 to 2 hours is required for measurable improvement in the prothrombin time. Whole blood or component therapy may be necessary if the bleeding is severe.

Phytonadione will not counteract the anticoagulant action of heparin.

Repeated large doses of vitamin K are not warranted in hepatic disease if the response to the initial therapy is unsatisfactory. Failure to respond to vitamin K may indicate that the condition being treated is inherently unresponsive to vitamin K.

DailyMed RxNorm Mappings#

RxCUI, RxNorm string, TTY table
RxCUIRxNorm stringTTYSPL version
312423vitamin K1 10 MG/ML Injectable SolutionSCD1
312423phytonadione 10 MG/ML Injectable SolutionSY1

DailyMed Pharmacologic Classes#

Class, Version, Type table
ClassVersionTypeEffective
PHYTONADIONE Pharmacologic Class Indexing2Indexing - Pharmacologic Class20180813

DailyMed Product Concepts#

Product concept, Relation, Version table
Product conceptRelationVersionEffective
16a2c1cd-ae95-d910-f03d-7e06b11dd243Product name520260202
653485de-0601-41e4-82db-7a60bb223e27Product name120251024
23fb3cda-2b50-f3d3-ebde-f542350bd77bProduct name420240828
081b54f0-4545-48b6-b854-03e1401f09eaProduct name120230112
aead65a2-216e-4ff8-a178-44aab77c24edProduct name120180531
ed912195-5da0-0f2f-6f4b-3ef17710cbe3Product name120140508

DailyMed Package Descriptions#

Package NDC, Product, Description table
Package NDCProductDescriptionFormQuantityStrengthSPL version
59051-9089-5Vitamin K1 Injectable100 mL in 1 VIAL, MULTI-DOSEINJECTION1001

DailyMed Dashboard NDC Coverage#

NDC, Dashboard title, SPL version table
NDCDashboard titleSPL versionValidationDashboard ZIP
59051-9089VITAMIN K1 INJECTABLE (PHYTONADIONE) INJECTION [NEOGEN CORPORATION - NANDINO]11 package rows20150429_7a32a988-05f1-4b63-8175-5a744c65fa63.zip

DailyMed Socrata Ingredients#

Ingredient, Type, UNII table
IngredientTypeUNIISPL versionUploaded
PHYTONADIONEACTIVE INGREDIENTA034SE78571
PHYTONADIONEACTIVE MOIETYA034SE78571
BENZYL ALCOHOLINACTIVE INGREDIENTLKG8494WBH1
DEXTROSEINACTIVE INGREDIENTIY9XDZ35W21
PEG-40 CASTOR OILINACTIVE INGREDIENT4ERD2076EF1
WaterINACTIVE INGREDIENT059QF0KO0R1

Products#

Every source-derived product name is available through these pages.

DailyMed product names page 1 of 1 · 6 matching rows.

NDC Codes#

Product NDC, Package NDC table
Product NDCPackage NDC
59051-908959051-9089-5

Ingredients#

Every source-derived ingredient row is available through these pages.

DailyMed ingredient rows page 1 of 1 · 5 matching rows.

Source Document#

Source XML

Inactive ingredient matches#

Inactive Ingredient Database values describe FDA-listed use contexts. The match method and ambiguity count are shown because ingredient names, routes, and dosage forms are not always unique. Browse recovered IID releases and source provenance.

Inactive ingredient links page 1 of 2 · 72 matching rows.

DailyMed ingredient, IID ingredient, UNII table
DailyMed ingredientIID ingredientUNIIDosage form / routePotencyMaximum daily exposureMatch
DEXTROSEDEXTROSEIY9XDZ35W2SOLUTION / INTRAVENOUS5.05 %w/vExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, POWDER, LYOPHILIZED, FOR SOLUTION / INTRACAVERNOUS18 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSPRAY, METERED / NASAL5 mg/1mlExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, EMULSION / INTRAVENOUS45 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSPRAY / NASAL5 mgExact identifier — unii candidate
50 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2TABLET, EXTENDED RELEASE / ORAL103.95 mgExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / SUBCUTANEOUS90 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / SOFT TISSUE40 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / SUBCONJUNCTIVAL252 mgExact identifier — unii candidate
50 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2INJECTION / INTRAMUSCULAR5 %w/vExact identifier — unii candidate
21 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2POWDER / VAGINAL430 mgExact identifier — unii candidate
21 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2INJECTION, SOLUTION / INTRAVENOUS51.7 mgExact identifier — unii candidate
21 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2INJECTION / INTRAVENOUS5 %w/vExact identifier — unii candidate
21 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2LOZENGE / BUCCALNAExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSOLUTION / ORAL360 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / INTRAMUSCULAR1000 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, EMULSION / INTRAMUSCULAR225 mgExact identifier — unii candidate
50 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2SPRAY, METERED / NASAL50 mgExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHLOTION / TOPICAL4000 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, EMULSION / SUBCUTANEOUS225 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / INTRA-ARTICULAR1 %w/vExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SOLUTION / INTRAMUSCULAR500 mgExact identifier — unii candidate
50 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2SYRUP / ORAL620 mgExact identifier — unii candidate
21 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2TROCHE / ORAL903.5 mgExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUPPOSITORY / VAGINALNAExact identifier — unii candidate
50 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2INJECTION / INTRASPINAL75 mgExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHCAPSULE / ORAL450 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHLIQUID / INTRAVENOUS1.04 %w/vExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHTABLET / ORAL1.06 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUSPENSION / AURICULAR (OTIC)0.9 %w/vExact identifier — unii candidate
50 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2SOLUTION / ORAL2489 mg/5mlExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, POWDER, FOR SOLUTION / INTRAVENOUS144 mgExact identifier — unii candidate
50 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2TABLET / ORAL183.66 mgExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SOLUTION / INTRAVENOUS400 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUPPOSITORY / RECTAL129 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSHAMPOO / TOPICAL150 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / INTRASYNOVIAL18 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHOINTMENT / TOPICAL2.2 %w/wExact identifier — unii candidate
50 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2INJECTION, SOLUTION / INTRATHECAL1925 mgExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSOLUTION / INTRAMUSCULAR54 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHGEL / TOPICAL185 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / INTRALESIONAL23 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHTABLET, DELAYED RELEASE / ORAL2.31 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION / SOFT TISSUE23 mgExact identifier — unii candidate
50 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2TABLET, DELAYED RELEASE / ORALNAExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SOLUTION / INTRA-ARTICULAR23 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSOLUTION / INTRAVENOUS242 mgExact identifier — unii candidate
50 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2TABLET / SUBLINGUAL115.78 mgExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUSPENSION / ORAL100 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, POWDER, FOR SOLUTION / INTRAMUSCULAR144 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SUSPENSION / INTRA-ARTICULAR40 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHCREAM / TOPICAL160 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHINJECTION, SOLUTION / SUBCUTANEOUS0.95 %w/vExact identifier — unii candidate
50 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2POWDER, FOR SOLUTION / ORALNAExact identifier — unii candidate
21 equally ranked IID candidates
PEG-40 CASTOR OILPEG-40 CASTOR OIL4ERD2076EFTABLET / ORAL9 mgExact identifier — unii candidate
DEXTROSEDEXTROSEIY9XDZ35W2CONCENTRATE / ORAL400 mgExact identifier — unii candidate
21 equally ranked IID candidates
DEXTROSEDEXTROSEIY9XDZ35W2PASTILLE / ORAL826 mgExact identifier — unii candidate
21 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHGEL / RECTAL124 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHGEL / VAGINAL100 mgExact identifier — unii candidate
50 equally ranked IID candidates
BENZYL ALCOHOLBENZYL ALCOHOLLKG8494WBHSUSPENSION / TOPICAL100 mgExact identifier — unii candidate
50 equally ranked IID candidates

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 2 · 35 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
PHYTONADIONEPHYTONADIONEHenry Schein, Inc.0d971993-466c-46dd-bdd6-2e300173621e2026-11-06Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PHYTONADIONEPHYTONADIONEHenry Schein, Inc.1cf90be3-a744-4db5-999d-a84c673723042026-11-06Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PhytonadionePHYTONADIONESafecor Health, LLC4eca41d2-467a-4d62-a206-36dee802d0b62026-11-05Adverse reactionsName fallback
generic name: PHYTONADIONE
PhytonadionePHYTONADIONEDr.Reddys Laboratories Inc226c0a5c-3e04-65a9-01ac-e67aad9a430a2026-09-30Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PHYTONADIONEPHYTONADIONEHF Acquisition Co LLC, DBA HealthFirst5686f34b-446a-00ae-e063-6394a90a60292026-08-19Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
Vitamin K1PHYTONADIONEHospira, Inc.e8808230-2c44-44c6-8cab-8f29b6b340512026-08-09Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PHYTONADIONEPHYTONADIONESun Pharmaceutical Industries, Inc.51c175dd-02f9-68d1-e063-6294a90a4b362026-04-10Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PHYTONADIONEPHYTONADIONEAmneal Pharmaceuticals Private Limitedddd351d3-8b9e-482d-9ab8-f367ce1c3cc02026-03-31Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PHYTONADIONEPHYTONADIONEPadagis US LLC68701a07-2921-4443-bff3-76e261a9eb182026-03-31Adverse reactionsName fallback
generic name: PHYTONADIONE
PHYTONADIONEPHYTONADIONEOrbicular Pharmaceutical Technologies Private Limitedd954e3d7-a4d5-4798-887d-7af916ff01812026-03-24Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PhytonadionePHYTONADIONEMajor Pharmaceuticals54f23bc8-d8f3-40e8-a93d-3121cc581d542026-03-16Adverse reactionsName fallback
generic name: PHYTONADIONE
PhytonadionePHYTONADIONESagent Pharmaceuticals3d571642-3d3a-41ae-855e-304ae4fff4592026-02-04Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PhytonadionePHYTONADIONEGLENMARK PHARMACEUTICALS INC60e5abd1-e2fa-4a5e-b25b-3ec6cfdeed142025-12-18Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PhytonadionePHYTONADIONEAgnitio Inc.66ada4f8-c5a9-49f1-848f-e172416892a12025-12-01Adverse reactionsName fallback
generic name: PHYTONADIONE
phytonadionePHYTONADIONEAmneal Pharmaceuticals LLC2ce1dd90-11ad-4f74-af16-45b7e59f05da2025-10-23Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PhytonadionePHYTONADIONEAlembic Pharmaceuticals Limited6ccb76ab-1549-4a47-a119-8059588ad83d2025-09-11Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PhytonadionePHYTONADIONEAlembic Pharmaceuticals Inc.b1e53422-c85d-4bb6-af4f-24934cc319b02025-09-11Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PhytonadionePHYTONADIONECoupler LLC3e4f86c4-7e89-c864-e063-6394a90a59af2025-09-08Adverse reactionsName fallback
generic name: PHYTONADIONE
PhytonadionePHYTONADIONEXiromed LLCa4b394e7-b766-824e-a8bf-f56808de76e12025-08-21Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE
PhytonadionePHYTONADIONECaplin Steriles Limited114b1330-6f03-476c-8678-8cd0da189bce2025-04-26Boxed warning, Warnings, Adverse reactionsName fallback
generic name: PHYTONADIONE

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.